Learn more about our policy experts.

Media Contacts

Angela Bradbery, Director of Communications
w. (202) 588-7741
c. (202) 503-6768
abradbery@citizen.org, Twitter

Don Owens, Deputy Director of Communications
w. (202) 588-7767

Karilyn Gower, Press Officer
w. (202) 588-7779

David Rosen, Press Officer, Regulatory Affairs
w. (202) 588-7742

Other Important Links

Press Release Database
Citizen Vox blog
Texas Vox blog
Consumer Law and Policy blog
Energy Vox blog
Eyes on Trade blog

Follow us on Twitter


 Dec. 9, 2011

Ortho Evra Birth Control Patch Needlessly Exposes Patients to Excessive Levels of Hormones, Should Be Removed From Market

Birth Control Patch Delivers More Than Twice the Amount of Hormones as Oral Contraceptives

WASHINGTON, D.C. – The Ortho Evra birth control patch exposes women to dangerously high levels of estrogen and increased risk of blood clots and should be removed from the market, phased in over six months to allow women to switch to an alternative form of contraception, Public Citizen told two Food and Drug Administration (FDA) advisory committees today.

In fact, the Ortha Evra patch delivered estrogen (ethinyl estradiol) at levels approximately 60 percent higher than oral contraceptives, Public Citizen said in testimony to the FDA’s Drug Safety and Risk Management and Reproductive Health Drugs advisory committees.

There are more than 60 birth control pills on the market, all with a maximum of only 35 micrograms (mcg) of ethinyl estradiol or less. Comparatively, the Ortha Evra patch contains an equivalent exposure of estrogen that women would get with a 60-mcg pill.

“A pill delivering such an exposure would never be approved,” said Dr. Sidney Wolfe, director of Public Citizen’s Health Research Group. “If the Ortha Evra patch has no unique benefits and, relative to equally effective oral contraceptives with lower estrogen doses, has a higher risk of blood clots, there is no reason to leave it on the market. Although prescriptions have dropped markedly in the past seven years, more than a million prescriptions a year are still filled for the patch. Women using these prescriptions are at increased risk with no significant, documented benefit.”

Public Citizen is a national, nonprofit consumer advocacy organization based in Washington, D.C. For more information, please visit www.citizen.org.

Copyright © 2016 Public Citizen. Some rights reserved. Non-commercial use of text and images in which Public Citizen holds the copyright is permitted, with attribution, under the terms and conditions of a Creative Commons License. This Web site is shared by Public Citizen Inc. and Public Citizen Foundation. Learn More about the distinction between these two components of Public Citizen.

Public Citizen, Inc. and Public Citizen Foundation


You can support the fight for greater government and corporate accountability through a donation to either Public Citizen, Inc., or Public Citizen Foundation, Inc.

Public Citizen lobbies Congress and federal agencies to advance Public Citizen’s mission of advancing government and corporate accountability. When you make a contribution to Public Citizen, you become a member of Public Citizen, showing your support and entitling you to benefits such as Public Citizen News. Contributions to Public Citizen are not tax-deductible.

Public Citizen Foundation focuses on research, public education, and litigation in support of our mission. By law, the Foundation can engage in only very limited lobbying. Contributions to Public Citizen Foundation are tax-deductible.